| Towards host-directed therapies for tuberculosis A Zumla, J Chakaya, M Hoelscher, F Ntoumi, R Rustomjee, C Vilaplana, ... Nature reviews Drug discovery 14 (8), 511-512, 2015 | 130 | 2015 |
| Level of viral load and antiretroviral resistance after 6 months of non-nucleoside reverse transcriptase inhibitor first-line treatment in HIV-1-infected children in Mali D Germanaud, A Derache, M Traore, Y Madec, S Toure, F Dicko, ... Journal of antimicrobial chemotherapy 65 (1), 118-124, 2010 | 70 | 2010 |
| Factors associated with a low HIV reservoir in patients with prolonged suppressive antiretroviral therapy S Fourati, P Flandre, R Calin, G Carcelain, C Soulie, S Lambert-Niclot, ... Journal of Antimicrobial Chemotherapy 69 (3), 753-756, 2014 | 65 | 2014 |
| Invasive Nontyphoidal Salmonella Infections Among Children in Mali, 2002–2014: Microbiological and Epidemiologic Features Guide Vaccine Development MD Tapia, SM Tennant, K Bornstein, U Onwuchekwa, B Tamboura, ... Clinical Infectious Diseases 61 (suppl_4), S332-S338, 2015 | 60 | 2015 |
| Genetic barriers for integrase inhibitor drug resistance in HIV type-1 B and CRF02_AG subtypes AI Maïga, I Malet, C Soulie, A Derache, V Koita, B Amellal, L Tchertanov, ... Antiviral therapy 14 (1), 123-129, 2009 | 58 | 2009 |
| Very high prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in bacteriemic patients hospitalized in teaching hospitals in Bamako, Mali SA Sangare, E Rondinaud, N Maataoui, AI Maiga, I Guindo, A Maiga, ... PLoS One 12 (2), e0172652, 2017 | 57 | 2017 |
| Seroprevalence and risk factors for HIV, HCV, HBV and syphilis among blood donors in Mali A Jary, S Dienta, V Leducq, Q Le Hingrat, M Cisse, AB Diarra, DB Fofana, ... BMC Infectious Diseases 19, 1-8, 2019 | 52 | 2019 |
| Evolution of genetic diversity and drug resistance mutations in HIV-1 among untreated patients from Mali between 2005 and 2006 A Derache, AI Maiga, O Traore, A Akonde, M Cisse, B Jarrousse, V Koita, ... Journal of Antimicrobial Chemotherapy 62 (3), 456-463, 2008 | 52 | 2008 |
| Characterization of HIV-1 antiretroviral drug resistance after second-line treatment failure in Mali, a limited-resources setting AI Maiga, DB Fofana, M Cisse, F Diallo, MY Maiga, HA Traore, IA Maiga, ... Journal of antimicrobial chemotherapy 67 (12), 2943-2948, 2012 | 51 | 2012 |
| Resistance-associated mutations to etravirine (TMC-125) in antiretroviral-naive patients infected with non-B HIV-1 subtypes AI Maïga, D Descamps, L Morand-Joubert, I Malet, A Derache, M Cisse, ... Antimicrobial agents and chemotherapy 54 (2), 728-733, 2010 | 49 | 2010 |
| Host-directed therapies for tackling multi-drug resistant tuberculosis: learning from the Pasteur-Bechamp debates A Zumla, M Maeurer, ... Clinical Infectious Diseases 61 (9), 1432-1438, 2015 | 43 | 2015 |
| Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae isolated from blood cultures in Africa SA Sangare, AI Maiga, I Guindo, A Maiga, N Camara, S Savadogo, ... Medecine et maladies infectieuses 45 (9), 374-382, 2015 | 41 | 2015 |
| Climatic and anthropogenic impacts on the flow regime of the Nakambe River in Burkina Faso G Mahe, A Dray, JE Paturel, A Cres, F Koné, M Manga, FN Crès, ... International Association of Hydrological Sciences, Publication, 69-76, 2002 | 39 | 2002 |
| Prevalence of ESBL-producing Enterobacteriaceae isolated from blood cultures in Mali SA Sangare, AI Maiga, I Guindo, A Maiga, N Camara, OA Dicko, S Diallo, ... The Journal of Infection in Developing Countries 10 (10), 1059-1064, 2016 | 34 | 2016 |
| Cancer du sein dans deux centres hospitaliers de Bamako (Mali): aspects diagnostiques et thérapeutiques A Togo, A Traoré, C Traoré, BT Dembélé, L Kanté, I Diakité, A Maiga, ... Journal africain du cancer/African Journal of Cancer 2 (2), 88-91, 2010 | 34 | 2010 |
| Prevalence of pretreatment HIV drug resistance in West African and Southeast Asian countries N Ngo-Giang-Huong, THK Huynh, AY Dagnra, TA Toni, AI Maiga, D Kania, ... Journal of Antimicrobial Chemotherapy 74 (2), 462-467, 2019 | 32 | 2019 |
| HIV drug resistance after the use of generic fixed-dose combination stavudine/lamivudine/nevirapine as standard first-line regimen AG Marcelin, B Jarrousse, A Derache, M Ba, M Dakouo, A Doumbia, ... Aids 21 (17), 2341-2343, 2007 | 32 | 2007 |
| High level of HIV-1 resistance in patients failing long-term first-line antiretroviral therapy in Mali DB Fofana, C Soulié, A Baldé, S Lambert-Niclot, M Sylla, Z Ait-Arkoub, ... Journal of Antimicrobial Chemotherapy 69 (9), 2531-2535, 2014 | 31 | 2014 |
| Evaluation des impacts biophysiques et socio-économiques des investissements dans les actions de gestion des ressources naturelles au Nord du Plateau Central du Burkina Faso A Belemvire, A Maiga, H Sawadogo, M Savadogo, S Ouedraogo Rapport de synthèse 94, 2008 | 31 | 2008 |
| High rates of baseline drug resistance and virologic failure among ART-naive HIV-infected children in Mali CS Crowell, AI Maiga, M Sylla, B Taiwo, N Kone, AP Oron, RL Murphy, ... The Pediatric infectious disease journal 36 (11), e258-e263, 2017 | 29 | 2017 |
Anne-Genevieve MarcelinSorbonne UniversitéVerified email at aphp.fr
